Status:
NOT_YET_RECRUITING
Multimodal Cardiovascular and Hepatic Population Imaging
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Healthy Volunteers
Imaging Evaluation
Eligibility:
All Genders
20+ years
Brief Summary
Medical imaging is increasingly important for understanding diseases, detecting them early, and personalizing treatments. New imaging techniques, which can measure processes in the body without surger...
Eligibility Criteria
Inclusion
- Participation to the Constances cohort
- Age ≥ 20 years
- No overt cardiovascular or hepatic disease or related symptoms
- No known family or personal genetic disease
- Affiliation with a social security scheme or beneficiary of such a scheme.
- Agreement to sign the consent
Exclusion
- Renal function impairment with GFR \< 60 mL/min/1.73m2
- Deprived of liberty or persons subject to a legal protection measure (under guardianship or trusteeship)
- People with contraindications to MRI (claustrophobia, presence of metallic elements…)
- Pregnant or breastfeeding woman (pregnancy urinary test before inclusion for women of childbearing age).
Key Trial Info
Start Date :
October 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 14 2033
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT06906042
Start Date
October 15 2025
End Date
March 14 2033
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pitié-Salpêtrière
Paris, France